Replies to post #35333 on OncoSec Medical Inc (ONCSQ)

[Titan V]

Well I googled "Feuerstein Oncosec Twitter" and came up with one more:

More from $ONCS PR: % CRs down wrt p1. Only 9% of patients get at least 3 months of disease stabilization....mmmm, when does the p3 start?

— Juan P. Serrate, DVM (@JPZaragoza1) December 16, 2013

Also from a previous search:
https://plus.google.com/+BradLoncar/posts/8bWP3MZsyHA (see the comments section)

I'm on my way to New York. Will be at the Maidstone Cancer Immunotherapy Conference tomorrow.

— Brad Loncar (@bradloncar) March 25, 2015

$ONCS sent out a corporate advertisement via Bloomberg Businessweek. https://t.co/T86GvLYuG0

— Brad Loncar (@bradloncar) May 2, 2016

Brad Loncar manages the Loncar Immunotherapy index. If ONCS market cap were above $100M, it could have, maybe, made it on the index. Also, Brad liked Feuerstein's tweet from my previous post. I know, I have had too much free time today LOL!

But on a serious note, you are right, these prices are a gift if P2B data can hit a home run.